surmount 5 tirzepatide ESC 2025: post-hoc SURMOUNT-5 data affirms tirzepatide's lead in CVD risk reduction Mean percent weight loss change
Description
Offered in 0 more formats Are you a man taking Ozempic, Wegovy, Mounjaro, or other GLP-1 medications
Not terrible, but not confidence-inspiring either
American Medical Association: What Doctors Wish Patients Knew About Anti-Obesity Medication Harvard Health Publishing: GLP-1 Diabetes and Weight Loss Drug Side Effects U.S
Or are you just concerned the conversation will be awkward
The following strategies can help patients tolerate treatment and reduce the likelihood of complications: Gradual dose escalation is fundamental to tolerability
